|
|
|
| home > pmps > summer 2003 > digital watermarking for protection of pharmaceutical packaging |
|
|
 PUBLICATIONS |
Pharmaceutical Manufacturing and Packing Sourcer
|
The problem of pharmaceutical falsification is well documented if not well tracked. It is assumed that the reader understands the nature of the problem and the impact on public health, corporate reputation, brand image and the financial bottom line. Any single incident of falsification can negatively affect all four. Published information from sources including the World Health Organization, US congressional hearings and the International Chamber of Commerce estimate the international trafficking in falsified drugs as high as six per cent of international pharmaceutical sales, and over 50 per cent in some African countries.
The word falsification is used because a significant percentage of illegal trade is in genuine product that has been otherwise mislabelled, diverted or had expiration dates altered. Falsification may cover one of the following activities:
|
Read full article from PDF >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
By J Scott Carr, President of Digimarc Watermarking Solutions
J Scott Carr has more than 18 years' experience in sales and business development, strategic marketing and software development, with a focus on complex systems, security, electronic commerce and interactive media. Mr Carr joined Digimarc in 1996.
Today, as President of Digimarc Watermarking Solutions, he oversees all aspects of the company's digital watermarking operation, which includes engineering, R&D, sales, marketing and finance organisations, delivery of digital watermarking solutions focused on financial services, secure ID and digital image management. Previously, he was responsible for Digimarc's digital watermarking business in the financial systems market, including management of a multi-year anticounterfeiting project with an international consortium of central banks.
|
|
|
|
|
|
 |
Industry Events |
 |
BIO-Europe Spring® 2012 — 6th International Partnering Conference
19-21 March 2012, Amsterdam RAI Convention Center, Amsterdam, The Netherlands
BIO-Europe Spring is the springtime counterpart to EBD Group’s flagship conference, BIO-Europe, and continues the tradition of providing life science companies with high caliber partnering opportunities. Featuring EBD Group’s sophisticated, web-based partnering system, partneringONE®, the event enables delegates to efficiently identify, meet and get partnerships started with companies across the life science value chain, from large biotech and pharma companies to financiers and innovative start-ups.
More info >> |
|
 |
News and Press Releases |
 |
More safety in drug packaging
In Germany like in the rest of the world, child safety in drug packaging is an issue that has not been properly solved yet. Today, Faubel, the custom label supplier based in Melsungen, provides a safe and economical solution consisting of an innovative safety label which can be affixed to the back of a tablet blister pack like an ordinary sticker.
More info >> |
|
|
